Philip Morris to invest $20 mln in firm developing inhaler -report

JERUSALEM, Jan 19 (Reuters) - Cigarette giant Philip Morris International will invest about $20 million in an Israeli start-up that developed a metered-dose vaporiser of raw plants for medical use, Israeli news website Calcalist reported on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.